For millions of years, frogs have flourished in microbial swamps yet rarely falling ill. To survive these hostile environments, they evolved potent chemical defenses. Now, scientists are learning to ...

Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.

Acquired resistance genes may allow bacteria to degrade or chemically modify antibiotics, rendering them ineffective. They ...

Empa researchers are therefore working on sensors that quickly identify resistant germs and recommend efficient treatment. The spread of antibiotic-resistant superbugs is plunging health care ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older: Philadelphia Friday, March 28, 202 ...

GSK’s oral antibiotic Blujepa (gepotidacin) has been approved by the US Food and Drug Administration (FDA) to treat ...

The emergence of antibiotic-resistant strains threatens to set back the world a hundred years to the age when even a minor ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

In a laboratory in Ulsan, South Korea, scientists have quietly pulled off what might become one of the most important ...

Although this bacteria is considered healthy in your intestines, outside the gut, it can cause serious infections, ...